294
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Alcohol, Tobacco, and Prescription Drugs: The Relationship With Illicit Drugs in the Treatment of Substance Users

, , , &
Pages 963-971 | Published online: 07 Jun 2012

REFERENCES

  • Agrawal, A., & Lynskey, M. T. (2009). Tobacco and cannabis co-occurence: Does route of administration matter?, Drug and Alcohol Dependence, 99, 240–247.
  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, 4th Ed., text revision. Washington DC, American Psychiatric Association.
  • Andrews, G., Hall, W. D., Teesson, M., & Henderson, S. (1999). The mental health of Australians. Canberra: Mental Health Branch: Commonwealth Department of Health and Aged Care.
  • Andrews, G., Henderson, S., & Hall, W. D. (2001). Prevalence, comorbidity, disability and service utilisation: Overview of the Australian National Mental Health Survey. British Journal of Psychiatry, 178, 145–153.
  • Andrews, G., & Peters, L. (1998). Psychometric properties of the CIDI. Social Psychiatry and Psychiatric Epidemiology, 33(2), 80–88.
  • Angold, A., Costello, E. J., & Erkanli, A. (2003). Comorbidity. Journal of Child Psychology and Psychiatry, 40(1), 57–87.
  • Anton, R. F., O'Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., (2006). Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence. Journal of the American Medical Association, 295(17), 2003–2017.
  • Berkson, J. (1947). Limitations of the application of fourfold table analysis to hospital data. Biometrics Bulletin, 2, 47–53.
  • Bleich, A., Gelkopf, M., Weizman, T., & Adelson, M. (2002). Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: Characteristics and a pharmacotherapeutic approach. Israel Journal of Psychiatry and Related Sciences, 39(2), 104–112.
  • Burling, T. A., Burling, A. S., & Latini, D. (2001). A controlled smoking cessation trial for substance-dependent patients. Journal of Consulting and Clinical Psychology, 69(2), 295–304.
  • Burns, L., & Teesson, M. (2002). Alcohol use disorders comorbid with anxiety, depression and drug use disorders: Findings from the Australian National Survey of Mental Health and Well Being. Drug and Alcohol Dependence, 68(3), 299–307.
  • Burns, L., Teesson, M., & O'Neill, K. (2005). The impact of comorbid anxiety and depression on alcohol treatment outcomes. Addiction, 100(6), 787–796.
  • Campbell, B. K., Wander, N., Stark, M. J., & Holbert, T. (1995). Treating cigarette smoking in drug-abusing clients. Journal of Substance Abuse Treatment, 12(2), 89–94.
  • Carroll, K. M., Fenton, L. R., Ball, S. A., Nich, C., Frankforter, T. L., Shi, J., (2004). Efficacy of Disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: A randomized placebo-controlled trial. Archives of General Psychiatry, 61(3), 264–272.
  • Cerda, M., Sagdeo, A., & Galea, S. (2008). Comorbid forms of psychopathology: Key patterns and future research directions. Epidemiologic Reviews, 30(1), 155–177.
  • Coffey, C., Lynskey, M., Wolfe, R., & Patton, G. C. (2000). Initiation and progression of cannabis use in a population-based Australian adolescent longitudinal study. Addiction, 95(11), 1679–1690.
  • Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the National Epidemiologic Survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566–576.
  • Copeland, J., Swift, W., & Rees, V. (2001). Clinical profile of participants in a brief intervention program for cannabis use disorder. Journal of Substance Abuse Treatment, 20(1), 45–52.
  • Darke, S., Ross, J., Mills, K., Teesson, M., Williamson, A., & Havard, A. (2009). Benzodiazepine use among heroin users: Baseline use, current use and clinical outcome. Drug and Alcohol Review, 28(3), 243–249.
  • De Sousa, A., & De Sousa, A. (2005). An open randomized study comparing Disulfiram and Acamprosate in the treatment of alcohol dependence. Alcohol and Alcoholism, 40(6), 545–548.
  • Degenhardt, L., & Hall, W. (2001). The relationship between tobacco use, substance-use disorders and mental health: Results from the National Survey of Mental Health and Well-being. Nicotine and Tobacco Research, 3, 225–234.
  • Degenhardt, L., & Hall, W. (2003). Patterns of co-morbidity between alcohol use and other substance use in the Australian population. Drug and Alcohol Review, 22(1), 7–13.
  • Degenhardt, L., Hall, W. D., & Lynskey, M. T. (2001). Alcohol, cannabis and tobacco use among Australians: A comparison of their associations with other drug use, other drug use disorders, affective and anxiety disorders, and psychosis. Addiction, 96, 1603–1614.
  • Farrell, M., Howes, S., Bebbington, P., Brugha, T., Jenkins, R., Lewis, G., (2001). Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. British Journal of Psychiatry, 179, 432–437.
  • Fergusson, D. M., & Horwood, L. J. (1997). Early onset cannabis use and psychosocial adjustment in young adults. Addiction, 92(3), 279–296.
  • Flannery, B. A., Morgenstern, J., McKay, J. R., Wechsberg, W. M., & Litten, R. Z. (2004). Co-occurring alcohol and cocaine dependence: Recent findings from clinical and field studies. Alcoholism: Clinical and Experimental Research, 28(6), 976–981.
  • Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). ‘Mini-Mental State’: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
  • Garbutt, J. C., Kranzler, H. R., O'Malley, S. S., Gastfriend, D. R., Pettinati, H. M., & Silverman, B. L., (2005). Efficacy and tolerability of long-acting injectable Naltrexone for alcohol dependence: A randomized controlled trial. Journal of the American Medical Association, 293(13), 1617–1625.
  • Gariti, P., Alterman, A. I., Mulvaney, F., Mechanic, K., Dhopesh, V., Yu, E., (2002). Nicotine intervention during detoxification and treatment for other substance use. American Journal of Drug and Alcohol Abuse, 28(4), 671–679.
  • George, T. P., Chawarski, M. C., Pakes, J., Carroll, K. M., Kosten, T. R., & Schottenfeld, R. S. (2000). Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: A preliminary trial. Biological Psychiatry, 47(12), 1080–1086.
  • Gossop, M., Marsden, J., Stewart, D., & Rolfe, A. (2000). Patterns of drinking and drinking outcomes among drug misusers: 1-year follow-up results. Journal of Substance Abuse Treatment, 19(1), 45–50.
  • Grant, B. F., Dawson, D. A., & Hasin, D. S. (2001). The alcohol use disorder and associated disabilities interview schedule –DSM-IV version. Bethesda, Md: National Institute on Alcohol Abuse and Alcoholism.
  • Grant, B. F., Goldstein, R. B., Chou, S. P., Huang, B., Stinson, F. S., Dawson, D. A., (2009). Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: Results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Molecular Psychiatry, 14, 1051–1066.
  • Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61, 807–816.
  • Grant, J. D., Scherrer, J. F., Lynskey, M. T., Lyons, M. J., Eisen, S. A., Tsuang, M. T., (2006). Adolescent alcohol use is a risk factor for adult alcohol and drug dependence: Evidence from a twin design. Psychological Medicine, 36, 109–118.
  • Grassi, M. C., Cioce, A. M., Guidici, F. D., Antonilli, L., & Nencini, P. (2007). Short-term efficacy of Disulfiram or Naltrexone in reducing positive urinalysis for both cocaine and cocaethylene in cocaine abusers: A pilot study. Pharmacological Research, 55(2), 117–121.
  • Hall, W., Degenhardt, L., & Teesson, M. (2004). Cannabis and psychotic disorders: An update. Drug and Alcohol Review, 23(4), 433–443.
  • Hall, W., Degenhardt, L., & Teesson, M. (2009). Understanding comorbidity between substance use, anxiety and affective disorders: Broadening the research base. Addictive Behaviors, 34(6–7), 526–530.
  • Hasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 64(7), 830–842.
  • Hersh, D., Van Kirk, J. R., & Kranzler, H. R. (1998). Naltrexone treatment of co-morbid alcohol and cocaine use disorders. Psychopharmacology, 139(1–2), 44–52.
  • Higgins, S. T., Budney, A. J., Bickel, W. K., & Foerg, F. E. (1994). Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Archives of General Psychiatry, 51(7), 568–576.
  • Hill, A. B. (1965). The environment and disease: Associations or causation? Proceedings of the Royal Society of Medicine 58, 95–300.
  • Hill, A. B. (1966). Principles of medical statistics, 8th ed. London: The Lancet.
  • Jenkins, R., Bebbington, P., Brugha, T., Farrell, M., Gill, B., Lewis, G., (1997). The national psychiatric morbidity surveys of Great Britain: Strategy and methods. Psychological Medicine, 27(4), 765–774.
  • Jessor, R., & Jessor, S. L. (1977). Problem behavior and psychosocial development: A longitudinal study of youth. New York: Academic Press.
  • John, U., Meyer, C., Rumpf, H. J., & Hapke, U. (2004). Smoking, nicotine dependence and psychiatric comorbidity: A population-based study including smoking cessation after three years. Drug and Alcohol Dependence, 76(3), 287–295.
  • Kandel, D. (1975). Stages in adolescent involvement in drug use. Science, 190(4217), 912–914.
  • Kendler, K. S., & Prescott, C. A. (2006). Genes, environment, and psychology: Understanding the causes of psychiatric and substance use disorders. New York: Guilford Press.
  • Kessler, R. C. (1995). The epidemiology of psychiatric comorbidity. In Tsuang, M., Tohen, M. & Zahner, G. (Eds.), Textbook of psychiatric epidemiology (pp. 179–179). New York: John Wiley and Sons.
  • Kessler, R. C., Berglund, P., Chiu, W. T., Demler, O., Heeringa, S., Hiripi, E., (2004). The US National Comorbidity Survey Replication (NCS-R): Design and field procedures. International Journal of Methods in Psychiatric Research, 13(2), 69–92.
  • Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617–627.
  • Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8–19.
  • Kessler, R. C., & Ustun, T. B. (2004). The World Mental Health (WMH) survey initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). International Journal of Methods in Psychiatric Research, 13(2), 93–121.
  • Kessler, R. C., & Wang, P. S. (2008). The descriptive epidemiology of commonly occurring mental disorders in the United States. Annual Review of Public Health, 29, 115–129.
  • Lai, S., Lai, H., Page, B., & McCoy, C. B. (2000). The association between cigarette smoking and drug abuse in the United States. Journal of Addictive Diseases, 19(4), 11–24.
  • Lewinsohn, P. M., Rohde, P., & Brown, R. A. (1999). Level of current and past adolescent cigarette smoking as predictors of future substance use disorders in young adulthood. Addiction, 94(6), 913–921.
  • Lewis, G., Pelosi, A. J., Araya, R., & Dunn, G. (1992). Measuring psychiatric disorder in the community: A standardized assessment for use by lay interviewers. Psychological Medicine, 22(2), 465–486.
  • Lynskey, M. T., Heath, A. C., Bucholz, K. K., Slutske, W. S., Madden, P. A., Nelson, E. C., (2003). Escalation of drug use in early-onset cannabis users vs co-twin controls. Journal of the American Medical Association, 289(4), 427–433.
  • Lytton, H. (1990). Child and parent effects in boys’ conduct disorder: A reinterpretation. Development Psychology, 26(5), 683–697.
  • Magura, S. (2000). Introduction: Program quality in substance dependency treatment. Substance Use and Misuse, 35(12–14), 1617–1627.
  • McKay, J. R., Alterman, A. I., Rutherford, M. J., Cacciola, J. S., & McLellan, A. T. (1999). The relationship of alcohol use to cocaine relapse in cocaine dependent patients in an aftercare study. Journal of Studies on Alcohol, 60(2), 176–180.
  • Mengis, M. M., Maude-Griffin, P. M., Delucchi, K., & Hall, S. M. (2002). Alcohol use affects the outcome of treatment for cocaine abuse. American Journal on Addictions, 11(3), 219–227.
  • Miller, N. (1991). Special problems of the alcohol and multiple-drug dependent: Clinical interactions and detoxification. In R. Frances & S. Miller (Eds.), Clinical textbook of addictive disorders (pp. 194–218). New York: Guildford Press.
  • Moore, B. A., & Budney, A. J. (2001). Tobacco smoking in marijuana-dependent outpatients. Journal of Substance Abuse, 13(4), 583–596.
  • Navaratnam, V., & Foong, K. (1990). Opiate dependence –the role of benzodiazepines. Current Medical Research and Opinion, 11(10), 620–630.
  • Oslin, D. W., Pettinati, H. M., Volpicelli, J. R., Wolf, A. L., Kampman, K. M., & O'Brien, C. P. (1999). The effects of Naltrexone on alcohol and cocaine use in dually addicted patients. Journal of Substance Abuse Treatment, 16(2), 163–167.
  • Patton, G. C., Coffey, C., Carlin, J. B., Sawyer, S. M., & Lynskey, M. (2005). Reverse gateway?. Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction, 100(10), 1518–1525.
  • Petrakis, I. L., Carroll, K. M., Nich, C., Gordon, L. T., McCance-Katz, E. F., Frankforter, T., (2000). Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction, 95(2), 219–228.
  • Pettinati, H. M., Kampman, K. M., Lynch, K. G., Suh, J. J., Dackis, C. A., Oslin, D. W., (2008). Gender differences with high-dose naltrexone in patients with co-occuring cocaine and alcohol dependence. Journal of Substance Abuse Treatment, 34, 378–390.
  • Portney, L. G., & Watkins, M. P. (2000). Foundations of clinical research, 2nd ed. New Jersey, NJ: Prentice Hall.
  • Prochaska, J. J. (2010). Failure to treat tobacco use in mental health and addiction treatment settings: A form of harm reduction? Drug and Alcohol Dependence, 110(3), 177–182.
  • Project MATCH Research Group. (1997). Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol, 58, 7–29.
  • Project MATCH Research Group. (1998). Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research, 22(6), 1300–1311.
  • Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Journal of the American Medical Association, 264(19), 2511–2518.
  • Reinherz, H. Z., Giaconia, R. M., Hauf, A. M., Wasserman, M. S., & Paradis, A. D. (2000). General and specific childhood risk factors for depression and drug disorders by early adulthood. Journal of the American Academy of Child and Adolescent Psychiatry, 39(2), 223–231.
  • Roll, J. M., Higgins, S. T., Budney, A. J., Bickel, W. K., & Badger, G. J. (1996). A comparison of cocaine-dependent cigarette smokers and non-smokers on demographic, drug use and other characteristics. Drug and Alcohol Dependence, 40(3), 195–201.
  • Ross, J., & Darke, S. (2000). The nature of benzodiazepine dependence among heroin users in Sydney, Australia. Addiction, 95(12), 1785–1793.
  • Ross, J., Teesson, M., Darke, S., Lynskey, M., Ali, R., Ritter, A., (2005). The characteristics of heroin users entering treatment: Findings from the Australian Treatment Outcomes Study (ATOS). Drug and Alcohol Review, 24(5), 411–418.
  • Rutter, M. (1994). Family discord and conduct disorder: Cause, consequence, or correlate?. Journal of Family Psychology, 8(2), 170–186.
  • Schiff, M., Levit, S., & Moreno, S. C. (2007). Retention and illicit drug use among methadone patients in Israel: A gender comparison. Addictive Behaviors, 32(10), 2108–2119.
  • Schmitz, J. M., Bordnick, P. S., Kearney, M. L., Fuller, S. M., & Breckenridge, J. K. (1997). Treatment outcome of cocaine-alcohol dependent patients. Drug and Alcohol Dependence, 47, 55–61.
  • Schmitz, J. M., Stotts, A. L., Sayre, S. L., DeLaune, K. A., & Grabowski, J. (2004). Treatment of cocaine–alcohol dependence with Naltrexone and relapse prevention therapy. American Journal on Addictions, 13(4), 333–341.
  • Shoptaw, S., Rotheram-Fuller, E., Yang, X., Frosch, D., Nahom, D., Jarvik, M. E., (2002). Smoking cessation in methadone maintenance. Addiction, 97(10), 1317–1328.
  • Simpson, D. D., Joe, G. W., Broome, K. M., Hiller, M. L., Knight, K., & Rowan-Szal, G. A. (1997). Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11(4), 279–293.
  • Slade, T., Johnston, A., Oakley Browne, M. A., Andrews, G., & Whiteford, H. (2009). 2007 National Survey of Mental Health and Wellbeing: Methods and key findings. Australian and New Zealand Journal of Psychiatry, 43(7), 594–605.
  • Stein, M. D., Weinstock, M. C., Herman, D. S., Anderson, B. J., Anthony, J. C., & Niaura, R. (2006). A smoking cessation intervention for the methadone-maintained. Addiction, 101(4), 599–607.
  • Stenbacka, M., Beck, O., Leifman, A., Romelsj, A., & Helander, A. (2007). Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment. Drug and Alcohol Review, 26(1), 55–63.
  • Story, J., & Stark, M. J. (1991). Treating cigarette smoking in methadone maintenance clients. Journal of Psychoactive Drugs, 23(2), 203–215.
  • Teesson, M., Hall, W., Slade, T., Mills, K., Grove, R., Mewton, L., (2010). Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: Findings of the 2007 National Survey of Mental Health and Welbeing. Addiction, 105, 1–10.
  • Teesson, M., Mills, K., Ross, J., Darke, S., Williamson, A., & Havard, A. (2008). The impact of treatment on 3 years’ outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addiction, 103(1), 80–88.
  • Teesson, M., Slade, T., & Mills, K. (2009). Comorbidity in Australia: Findings of the 2007 National Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Psychiatry, 43(7), 606–614.
  • Timberlake, D. S., Haberstick, B. C., Hopfer, C. J., Bricker, J., Sakai, J. T., Lessem, J. M., (2007). Progression from marijuana use to daily smoking and nicotine dependence in a national sample of US adolescents. Drug and Alcohol Dependence, 88(2–3), 272–281.
  • Tonnesen, P., Paoletti, P., Gustavsson, G., Russell, M. A., Saracci, R., Gulsvik, A., (1999). Higher dosage nicotine patches increase one-year smoking cessation rates: Results from the European CEASE trial. European Respiratory Journal, 13, 238–246.
  • Tsuang, M. T., Bar, J. L., Harley, R. M., & Lyons, M. J. (2001). The Harvard twin study of substance abuse: What we have learned. Harvard Review of Psychiatry, 9(6), 267–279.
  • Tullis, L. M., Dupont, R., Frost-Pineda, K., & Gold, M. S. (2003). Marijuana and tobacco: a major connection? Journal of Addictive Diseases, 22(3), 51–62.
  • Ware, J. E., Kosinski, M., & Keller, S. D. (1996). A 12-item short form health survey. Medical Care, 34, 220–233.
  • Williamson, A., Darke, S., Ross, J., & Teesson, M. (2006). The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence. Drug and Alcohol Dependence, 81(3), 293–300.
  • Wiseman, E. J., & McMillan, D. E. (1996). Combined use of cocaine with alcohol and cigarettes. American Journal of Drug and Alcohol Abuse, 22(4), 577–587.
  • Wiseman, E. J., Williams, D. K., & McMillan, D. E. (2005). Effectiveness of payment for reduced carbon monoxide levels and noncontingent payments on smoking behaviors in cocaine-abusing outpatients wearing nicotine or placebo patches. Experimental and Clinical Psychopharmacology, 13(2), 102–110.
  • Wittchen, H.-U., Beloch, E., Garczynski, E., Holly, A., Lachner, G., Perkonigg, A., (1995). Munchener Composite International Diagnostic Interview (M-CIDI), version 2.2. Munich: Max-Planck-Institut fur Psychiatrie.
  • World Health Organization. (1990). Composite International Diagnostic Interview (CIDI), Version 1.0. Geneva: World Health Organization.
  • World Health Organization. (1993). The ICD-10 classification of mental and behavioural disorders. Geneva: World Health Organization.
  • Young, S. E., Mikulich, S. K., Goodwin, M. B., Hardy, J., Martin, C. L., Zoccolillo, M. S., (1995). Treated delinquent boys’ substance use: Onset, pattern, relationship to conduct and mood disorders. Drug and Alcohol Dependence, 37, 149–162.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.